We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
UK biotech racing to keep antibody up to date with latest variants
Shortage of doctors with university posts is putting health service on ‘dangerous precipice’
Short-termism and suspicion in parts of government risk our valuable future in precision medicine
Officials row with Pfizer over price as villages struggle to obtain antiviral medication
Future of pandemic less predictable than at the outset because of new variants, says Jenny Harries
Beijing reports almost 60,000 deaths in month since abandoning pandemic restrictions
Starting with primary care, investment combined with modernisation can deliver better outcomes for patients
Effort to improve health supply chain issues that have led to Greece imposing an export ban on drugs
For all its landmark status, lecanemab may end up representing a triumph of hope over evidence
Covid vaccine maker looks to use machine learning to help discover new treatments
Hong Kong-based lender seeks to cater to mainlanders’ demand for western jabs
Beijing accuses countries of ‘political manipulation’ for introducing testing requirements during exit wave
Narrow definition of cases leaves claimants on the hook after state-backed policies drop free care
Also in this edition: eurozone unemployment falls to new low, uproar in Brazil and Rolls-Royce hits sales record
Pharmaceutical groups to part ways with longstanding executives
South Korean vaccine maker looks elsewhere to expand overseas business
Bid to extend tech throughout city state to wipe out disease-carrying mosquito population
High price of treatment and restrictions on medicine developed by Eisai and Biogen will limit patient access initially
Jab developed by CanSinoBio could help nation grappling with a wave of infection
Covid and flu hospitalisations soar over Christmas as emergency service delays worsen
Daiichi Sankyo and AstraZeneca’s Enhertu could double time patients can live without their condition progressing
Covid-19 vaccine maker hails ‘huge’ investment aimed at recruiting 10,000 participants with NHS
While most children are back to the old routine, 3.7mn US households are still teaching their kids at home
A surge in cases after China lifted restrictions has sparked concerns that a dangerous new strain could emerge
Ministers want to supercharge the £89bn life science industry. But it will take long-term thinking on investment, talent and infrastructure
UK Edition
